Matthew Suffness
Impact in
- Toxicology top 5%
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Cancer therapeutics and mechanisms 4
- Natural product bioactivities and synthesis 3
- Phytochemical compounds biological activities 3
- Oncology 7
- Cancer Treatment and Pharmacology 5
- Co-authors
- John Douros (5 shared papers)Gordon M. Cragg (6 shared papers)Michael R. Grever (1 shared paper)Saul A. Schepartz (1 shared paper)David Newman (1 shared paper)Kenneth M. Snader (1 shared paper)Arnold Brossi (2 shared papers)S. Morris Kupchan (5 shared papers)
- Journals
- The Journal of Organic Chemistry (4 papers)Journal of the American Chemical Society (2 papers)Investigational New Drugs (2 papers)Economic Botany (2 papers)Journal of Natural Products (2 papers)
- Partner nations
- United StatesMalaysiaCosta Rica
In The Last Decade
Matthew Suffness
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Toxicology 67
- Pharmacology 282
- Pharmacology 138
- Biotechnology 131
- Molecular Biology 704
Countries citing papers authored by Matthew Suffness
This map shows the geographic impact of Matthew Suffness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Suffness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Suffness more than expected).
Fields of papers citing papers by Matthew Suffness
This network shows the impact of papers produced by Matthew Suffness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Suffness. The network helps show where Matthew Suffness may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Suffness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 210 | |
| 2 | 1982 | 189 | |
| 3 | 1981 | 150 | |
| 4 | 1988 | 136 | |
| 5 | 1989 | 104 | |
| 6 | 1986 | 71 | |
| 7 | 1996 | 63 | |
| 8 | 1985 | 53 | |
| 9 | 1988 | 40 | |
| 10 | 1984 | 36 | |
| 11 | 1978 | 31 | |
| 12 | 1987 | 27 | |
| 13 | 1988 | 24 | |
| 14 | 1986 | 23 | |
| 15 | 1980 | 17 | |
| 16 | 1990 | 16 | |
| 17 | 1968 | 16 | |
| 18 | 1970 | 15 | |
| 19 | 1970 | 14 | |
| 20 | 1985 | 12 |
About Matthew Suffness
Matthew Suffness is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Pharmacology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Natural product bioactivities and synthesis (3 papers), Phytochemical compounds biological activities (3 papers), Synthesis and Biological Evaluation (3 papers), Phytochemistry and Bioactive Compounds (3 papers) and Lichen and fungal ecology (2 papers). The work is most often cited by research in Toxicology (67 citations), Pharmacology (282 citations), Pharmacology (138 citations), Biotechnology (131 citations) and Molecular Biology (704 citations). Matthew Suffness has collaborated with scholars based in United States, Malaysia and Costa Rica. Frequent co-authors include John Douros, Gordon M. Cragg, Michael R. Grever, Saul A. Schepartz, David Newman, Kenneth M. Snader, Arnold Brossi, S. Morris Kupchan, Brian Leyland‐Jones and Charles K. Grieshaber. Their work appears in journals such as The Journal of Organic Chemistry, Journal of the American Chemical Society, Investigational New Drugs, Economic Botany and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.